Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,88119,900 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Development of Novel Metal-Based Supramolecular Therapeutics for Ovarian Cancer
NATIONAL CANCER INSTITUTE Kent State University United States 2021 – 2024

PROJECT SUMMARY Our goal in this R15 proposal is to engineer novel photoactivatable Pt(IV) metallodrugs for ovarian cancer therapy.Platinum-based metallodrugs are widely used in ov...

$4.55M
USD
Completed NON-SBIR/STTR RPGS
Genetic Predictors of Prostate Cancer Survival
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2025

Project Summary / Abstract Even though most men diagnosed with prostate cancer will not die of the disease, prostate cancer is still the second leading cause of cancer death among...

$7.37M
USD
Completed NON-SBIR/STTR RPGS
Genetic Predictors of Prostate Cancer Survival
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2025

Project Summary / Abstract Even though most men diagnosed with prostate cancer will not die of the disease, prostate cancer is still the second leading cause of cancer death among...

$2.23M
USD
Completed TRAINING, INDIVIDUAL
Investigating the Roles of Phospholipase A2s and Diacylglycerol Signaling in Ferroptosis
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2021 – 2024

PROJECT SUMMARY Despite rapid advances in cancer therapeutic development, acquired drug resistance continues to threaten the long-term efficacy of existing chemotherapeutic agents,...

$363.1K
USD
Completed NON-SBIR/STTR RPGS
Genetic Predictors of Prostate Cancer Survival
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2025

Prostate cancer (PC) has a very heterogenous clinical course. Many men have an indolent PC that can be safely watched for years without progression. Alternatively, other men have a...

$681.7K
USD
Completed NON-SBIR/STTR RPGS
Genetic predictors of prostate cancer survival
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT The underlying scientific premise of the parent grant is that the risk factors and mechanisms that drive prostate cancer development likely differ from tho...

$1.09M
USD
Completed NON-SBIR/STTR RPGS
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2021 – 2025

ABSTRACT. Colorectal cancer (CRC) is associated with multiple risk factors including, obesity, low fiber diets, and diets high in animal protein and saturated fat (SFat). African A...

$6.29M
USD
Completed NON-SBIR/STTR RPGS
Near-IR Ratiometric Fluorescence Probes for Assessing Cargo Delivery to Prostate Tumors
NATIONAL CANCER INSTITUTE Washington State University United States 2021 – 2022

PROJECT SUMMARY/ABSTRACT Prostate-specific membrane antigen (PSMA) is the hallmark enzyme-biomarker for prostate cancer because it is expressed in the epithelium of nearly all pros...

$2.25M
USD
Completed NON-SBIR/STTR RPGS
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2025

Abstract Pancreatic cancer is the leading cause of cancer-related death with less than 5% (5-year) survival rate with current treatment regimen involving chemo-radiation therapy. A...

$5.64M
USD
Completed NON-SBIR/STTR RPGS
Near-IR Ratiometric Fluorescence Probes for Assessing Cargo Delivery to Prostate Tumors
NATIONAL CANCER INSTITUTE Washington State University United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Prostate-specific membrane antigen (PSMA) is the hallmark enzyme-biomarker for prostate cancer because it is expressed in the epithelium of nearly all pros...

$1.73M
USD
Completed NON-SBIR/STTR RPGS
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2025

Abstract Pancreatic cancer is the leading cause of cancer-related death with less than 5% (5-year) survival rate with current treatment regimen involving chemo-radiation therapy. A...

$5.28M
USD
Completed NON-SBIR/STTR RPGS
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2025

Abstract Pancreatic cancer is the leading cause of cancer-related death with less than 5% (5-year) survival rate with current treatment regimen involving chemo-radiation therapy. A...

$4.73M
USD
Completed NON-SBIR/STTR RPGS
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2025

Abstract Pancreatic cancer is the leading cause of cancer-related death with less than 5% (5-year) survival rate with current treatment regimen involving chemo-radiation therapy. A...

$4.59M
USD
Completed TRAINING, INDIVIDUAL
Investigating the role of Eya3 in the regulation of innate immune signaling cascades in Triple Negative Breast Cancer
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT: Triple Negative Breast Cancer (TNBC) is a subtype of breast cancer characterized by low or absent expression of the estrogen receptor and the HER2 growth...

$351.5K
USD
Completed TRAINING, INDIVIDUAL
An Engineered Nanocarrier Platform for Enhancing Immune Responses to Neoantigen-Targeted Cancer Vaccines
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2021 – 2024

Project Summary Vaccines targeting cancer neoantigens have the potential to enhance the magnitude, function, and duration of an anti-tumor T cell response, offering a promising str...

$460.4K
USD
Completed NON-SBIR/STTR RPGS
Rational translation of gold nanoparticle mediated radiosensitization tothe clinic
NATIONAL CANCER INSTITUTE Mayo Clinic Jacksonville United States 2021 – 2025

The use of high atomic number (Z) elements as radiosensitizers of tumors has been well documented in the literature over the last few decades.In particular, gold nanoparticles (GNP...

$6.32M
USD
Completed NON-SBIR/STTR RPGS
Rational translation of gold nanoparticle mediated radiosensitization tothe clinic
NATIONAL CANCER INSTITUTE Mayo Clinic Jacksonville United States 2021 – 2022

The use of high atomic number (Z) elements as radiosensitizers of tumors has been well documented in the literature over the last few decades. In particular, gold nanoparticles (GN...

$5.91M
USD
Completed NON-SBIR/STTR RPGS
Relating Molecular Subgroups of Endometriosis-Associated Ovarian Cancers to Survival and Risk
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Ovarian cancer (OC) is the eleventh most common cancer and fifth deadliest among U.S. women. The low incidence, high fatality and molecularly broad range o...

$9.98M
USD
Completed TRAINING, INDIVIDUAL
Investigating the role of Eya3 in the regulation of innate immune signaling cascades in Triple Negative Breast Cancer
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT: Triple Negative Breast Cancer (TNBC) is a subtype of breast cancer characterized by low or absent expression of the estrogen receptor and the HER2 growth...

$356.6K
USD
Completed TRAINING, INDIVIDUAL
An Engineered Nanocarrier Platform for Enhancing Immune Responses to Neoantigen-Targeted Cancer Vaccines
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2021 – 2024

Project Summary Vaccines targeting cancer neoantigens have the potential to enhance the magnitude, function, and duration of an anti-tumor T cell response, offering a promising str...

$467.5K
USD